Validated using a knockout cell line
Recombinant
RabMAb

Recombinant Anti-ROCK2 antibody [EPR7141(B)] (ab125025)

Publishing research using ab125025? Please let us know so that we can cite the reference in this datasheet.

ab125025 has been referenced in 6 publications.

  • Tang L  et al. RhoA/ROCK signaling regulates smooth muscle phenotypic modulation and vascular remodeling via the JNK pathway and vimentin cytoskeleton. Pharmacol Res 133:201-212 (2018). PubMed: 29791873
  • Vieira GM  et al. Prognostic value and functional role of ROCK2 in pediatric Ewing sarcoma. Oncol Lett 15:2296-2304 (2018). PubMed: 29434937
  • Sun XQ  et al. Total flavones of Rhododendron simsii Planch flower protect isolated rat heart from ischaemia-reperfusion injury and its mechanism of UTR-RhoA-ROCK pathway inhibition. J Pharm Pharmacol 70:1713-1722 (2018). PubMed: 30251312
  • Majumder P  et al. Cellular levels of Grb2 and cytoskeleton stability are correlated in a neurodegenerative scenario. Dis Model Mech 10:655-669 (2017). PubMed: 28360125
  • Han Y  et al. Noise-induced cochlear F-actin depolymerization is mediated via ROCK2/p-ERM signaling. J Neurochem 133:617-28 (2015). ICC/IF ; Mouse . PubMed: 25683353
  • Cai SD  et al. MicroRNA-144 inhibits migration and proliferation in rectal cancer by downregulating ROCK-1. Mol Med Rep 12:7396-402 (2015). PubMed: 26458302

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
For licensing inquiries, please contact partnerships@abcam.com

Sign up